{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:51:11Z","timestamp":1773294671836,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.pnpbp.2006.08.005","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T15:18:44Z","timestamp":1158679124000},"page":"297-300","source":"Crossref","is-referenced-by-count":9,"title":["Fatal agranulocytosis: The use of olanzapine in a patient with schizophrenia and myelodysplasia"],"prefix":"10.1016","volume":"31","author":[{"given":"Emmanuel","family":"Stip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Thuot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adham","family":"Mancini-Mar\u00efe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pnpbp.2006.08.005_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1176\/appi.psy.44.1.83","article-title":"Olanzapine and haloperidol: potential for neutropenia?","volume":"44","author":"Abdullah","year":"2003","journal-title":"Psychosomatics"},{"issue":"9178","key":"10.1016\/j.pnpbp.2006.08.005_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(99)00957-5","article-title":"Olanzapine-induced neutropenia after clozapine-induced neutropenia","volume":"354","author":"Benedetti","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.08.005_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004850-200101000-00007","article-title":"Olanzapine-induced leukopenia with human leukocyte antigen profiling","volume":"16","author":"Buchman","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pnpbp.2006.08.005_bib5","first-page":"463","article-title":"Experiences with clozapine and olanzapine","volume":"32","author":"Chatterton","year":"1998","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.08.005_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/jama.1962.03050270056014c","article-title":"Agranulocytosis secondary to hydrochlorothiazide therapy. Report of a case","volume":"181","author":"Chrein","year":"1962","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pnpbp.2006.08.005_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/15622970410029938","article-title":"Reversible neutropenia during treatment with olanzapine: three case reports","volume":"5","author":"Cordes","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.08.005_bib2","unstructured":"Delieu, JM, Horobin, RW, Duguid, JK. Formation of immature neutrophil leucocytes in schizophrenic patients treated with various antipsychotic drugs: comparisons and predictions. J Psychopharmacol in press (Epub ahead of print)."},{"issue":"4","key":"10.1016\/j.pnpbp.2006.08.005_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00004850-200015040-00008","article-title":"Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone","volume":"15","author":"Dernovsek","year":"2000","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.pnpbp.2006.08.005_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-2007-979204","article-title":"Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine?","volume":"32","author":"Dettling","year":"1999","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2006.08.005_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1176\/appi.ajp.158.4.651","article-title":"Granulocytopenia with clozapine and quetiapine","volume":"158","author":"Diaz","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.08.005_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.jcp.0000117428.05703.16","article-title":"Olanzapine-induced neutropenia: mechanism and treatment","volume":"24","author":"Duggal","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.pnpbp.2006.08.005_bib12","first-page":"81","article-title":"A case of leukopenia in treatment with risperidone in an adolescent","volume":"26","author":"Etain","year":"2000","journal-title":"Encephale"},{"issue":"6","key":"10.1016\/j.pnpbp.2006.08.005_bib13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1176\/ajp.155.6.855a","article-title":"Risperidone-associated agranulocytosis","volume":"155","author":"Finkel","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.08.005_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.psy.41.2.150","article-title":"Olanzapine-induced neutropenia","volume":"41","author":"Gajwani","year":"2000","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.pnpbp.2006.08.005_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1176\/ajp.153.5.735b","article-title":"Agranulocytosis after addition of risperidone to clozapine treatment","volume":"153","author":"Godleski","year":"1996","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2006.08.005_bib16","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1176\/appi.ajp.158.10.1736-a","article-title":"Agranulocytosis and neutropenia with typical and atypical neuroleptics","volume":"158","author":"Hong","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.08.005_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00004850-200103000-00007","article-title":"Dose-dependent olanzapine-associated leukopenia: three case reports","volume":"16","author":"Kodesh","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.pnpbp.2006.08.005_bib18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00004714-200012000-00020","article-title":"Olanzapine prolongation of granulocytopenia after clozapine discontinuation","volume":"20","author":"Konakanchi","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.08.005_bib19","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1007\/BF00442575","article-title":"Leponex-associated granulocytopenia: a review of the situation","volume":"99","author":"Krupp","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.pnpbp.2006.08.005_bib20","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/1531-8257(199909)14:5<872::AID-MDS1026>3.0.CO;2-Y","article-title":"Reversible leucopenia related to olanzapine","volume":"14","author":"Meissner","year":"1999","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.08.005_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.genhosppsych.2005.08.005","article-title":"Ziprasidone-related agranulocytosis following olanzapine-induced neutropenia","volume":"28","author":"Montgomery","year":"2006","journal-title":"Gen Hosp Psychiatry"},{"issue":"9178","key":"10.1016\/j.pnpbp.2006.08.005_bib21","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0140-6736(99)03111-6","article-title":"Olanzapine-induced agranulocytosis","volume":"354","author":"Naumann","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.08.005_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004714-200004000-00032","article-title":"Olanzapine: safe during clozapine-induced agranulocytosis","volume":"20","author":"Oyewumi","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2006.08.005_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1034\/j.1600-0447.2001.00429.x","article-title":"Agranulocytosis and granulocytopenia associated with quetiapine","volume":"104","author":"Ruhe","year":"2001","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"10.1016\/j.pnpbp.2006.08.005_bib34","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.pnpbp.2005.11.032","article-title":"Prolongation of clozapine-induced leukopenia with olanzapine treatment","volume":"30","author":"Sayin","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.08.005_bib24","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1542\/peds.31.5.754","article-title":"Neutropenia in an infant secondary to hydrochlorothiazide therapy: with a review of hematologic reactions to \u201cthiazide\u201d drugs","volume":"31","author":"Schotland","year":"1963","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.08.005_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1600-0447.2000.102002153.x","article-title":"Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia","volume":"102","author":"Schuld","year":"2000","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"10.1016\/j.pnpbp.2006.08.005_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-2007-979222","article-title":"Two cases of olanzapine-induced reversible neutropenia","volume":"32","author":"Steinwachs","year":"1999","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2006.08.005_bib27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.pnpbp.2005.04.025","article-title":"Olanzapine-induced leucopenia and neutropenia","volume":"29","author":"Stergiou","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.pnpbp.2006.08.005_bib28","first-page":"S70","article-title":"Blood dyscrasias induced by psychotropic drugs","volume":"37","author":"Stubner","year":"2004","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.08.005_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4088\/JCP.v60n0209","article-title":"Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients","volume":"60","author":"Swartz","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2006.08.005_bib30","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4088\/JCP.v61n1111b","article-title":"Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution","volume":"61","author":"Teter","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2006.08.005_bib35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1176\/appi.ajp.163.7.1298","article-title":"Reversible neutropenia with olanzapine following clozapine-induced neutropenia","volume":"163","author":"Thangadurai","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2006.08.005_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0278-5846(01)00258-5","article-title":"Olanzapine-induced agranulocytosis: a case report and review of the literature","volume":"26","author":"Tolosa-Vilella","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2006.08.005_bib32","first-page":"81","article-title":"Olanzapine: hematological reactions","volume":"159","author":"Wray","year":"1998","journal-title":"CMAJ"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606003277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606003277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T22:46:49Z","timestamp":1736549209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606003277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0278584606003277"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.08.005","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}